Cargando…

Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study

[Image: see text]

Detalles Bibliográficos
Autores principales:	Vonk, Jasper, de Wit, Jaron G., Voskuil, Floris J., Koldijk, Marjolein, Rácz, Emőke, Hooghiemstra, Wouter T.R., Doff, Jan J., Diercks, Gilles F.H., van Dam, Gooitzen M., Witjes, Max J.H., de Visscher, Sebastiaan A.H.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804538/ https://www.ncbi.nlm.nih.gov/pubmed/35762264 http://dx.doi.org/10.1111/bjd.21722

Ejemplares similares

Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study
por: Voskuil, Floris Jan, et al.
Publicado: (2020)

Epidermal Growth Factor Receptor–Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer
por: Vonk, Jasper, et al.
Publicado: (2022)

Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers
por: Gao, Rebecca W., et al.
Publicado: (2018)

Near-Infrared Fluorescence Imaging of EGFR-Overexpressing Tumors in the Mouse Xenograft Model Using scFv-IRDye800CW and Cetuximab-IRDye800CW
por: Amini, Abolfazl, et al.
Publicado: (2022)

Feasibility of ex vivo fluorescence imaging of angiogenesis in (non-) culprit human carotid atherosclerotic plaques using bevacizumab-800CW
por: Huisman, Lydian A., et al.
Publicado: (2021)

EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial
por: de Wit, Jaron G., et al.
Publicado: (2023)

Towards Photodynamic Image-Guided Surgery of Head and Neck Tumors: Photodynamic Priming Improves Delivery and Diagnostic Accuracy of Cetuximab-IRDye800CW
por: Bhandari, Chanda, et al.
Publicado: (2022)

Detection of Tumour-Targeted IRDye800CW Tracer with Commercially Available Laparoscopic Surgical Systems
por: Sikkenk, Daan J., et al.
Publicado: (2023)

Anti-GD2-IRDye800CW as a targeted probe for fluorescence-guided surgery in neuroblastoma
por: Wellens, Lianne M., et al.
Publicado: (2020)

Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW
por: Krishnan, Giri, et al.
Publicado: (2021)

Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats
por: Marshall, Milton V., et al.
Publicado: (2010)

Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
por: Bernhard, Wendy, et al.
Publicado: (2021)

Improving oral cavity cancer diagnosis and treatment with fluorescence molecular imaging
por: Vonk, Jasper, et al.
Publicado: (2020)

Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab(®)-IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery
por: Polikarpov, Dmitry M., et al.
Publicado: (2020)

Tumor-Specific Imaging with Angiostamp800 or Bevacizumab-IRDye 800CW Improves Fluorescence-Guided Surgery over Indocyanine Green in Peritoneal Carcinomatosis
por: Josserand, Véronique, et al.
Publicado: (2022)

Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets
por: Cohen, Ruth, et al.
Publicado: (2011)

Near infrared fluorescence imaging of EGFR expression in vivo using IRDye800CW-nimotuzumab
por: Bernhard, Wendy, et al.
Publicado: (2017)

In Vivo Evaluation of Indium-111–Labeled 800CW as a Necrosis-Avid Contrast Agent
por: Stroet, Marcus C. M., et al.
Publicado: (2020)

Nanocolloidal albumin-IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node
por: Heuveling, Derrek A., et al.
Publicado: (2012)

Necrosis binding of Ac-Lys(0)(IRDye800CW)-Tyr(3)-octreotate: a consequence from cyanine-labeling of small molecules
por: Stroet, Marcus C. M., et al.
Publicado: (2021)

Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
por: Boss, Marti, et al.
Publicado: (2020)

Improved Multimodal Tumor Necrosis Imaging with IRDye800CW-DOTA Conjugated to an Albumin-Binding Domain
por: Stroet, Marcus C. M., et al.
Publicado: (2022)

The Use of Panitumumab-IRDye800CW in a Novel Murine Model for Conjunctival Squamous Cell Carcinoma
por: Youn, Gun Min, et al.
Publicado: (2022)

Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice
por: Okawa, Hiroko, et al.
Publicado: (2022)

A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies
por: Oliveira, Sabrina, et al.
Publicado: (2012)

IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts
por: Kurbegovic, Sorel, et al.
Publicado: (2021)

Multimodal image-guided surgery of HER2-positive breast cancer using [(111)In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor model
por: Deken, Marion M., et al.
Publicado: (2019)

Evaluation of Ac-Lys(0)(IRDye800CW)Tyr(3)-octreotate as a novel tracer for SSTR(2)-targeted molecular fluorescence guided surgery in meningioma
por: Dijkstra, Bianca M., et al.
Publicado: (2021)

First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800
por: Miller, Sarah E., et al.
Publicado: (2018)

Multispectral optoacoustic tomography for in vivo detection of lymph node metastases in oral cancer patients using an EGFR-targeted contrast agent and intrinsic tissue contrast: A proof-of-concept study
por: Vonk, J., et al.
Publicado: (2022)

A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent
por: Steinkamp, Pieter Jan, et al.
Publicado: (2021)

Manufacture of IRDye800CW-coupled Fe(3)O(4 )nanoparticles and their applications in cell labeling and in vivo imaging
por: Hou, Yong, et al.
Publicado: (2010)

In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors
por: Stroet, Marcus C. M., et al.
Publicado: (2021)

Correction to: Evaluation of Ac-Lys(0)(IRDye800CW)Tyr(3)-octreotate as a novel tracer for SSTR(2)-targeted molecular fluorescence guided surgery in meningioma
por: Dijkstra, Bianca M., et al.
Publicado: (2021)

Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with (89)Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts
por: ter Weele, Eva J., et al.
Publicado: (2015)

First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using (68)Ga-IRDye800CW-BBN
por: Li, Deling, et al.
Publicado: (2018)

Preclinical assessment of IRDye800CW‐labeled gastrin‐releasing peptide receptor‐targeting peptide for near infrared‐II imaging of brain malignancies
por: Zhang, Yuan, et al.
Publicado: (2023)

Portable CW Linac for Commercial Applications
por: Deruyter, H, et al.
Publicado: (1999)

The topology of CW complexes
por: Lundell, Albert T, et al.
Publicado: (1969)

Nikon D800 & D800E Digital Field Guide
por: Thomas, J
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_njdb2eqg88k0tcqhfb1s9vlid6